Back to Search
Start Over
13.2 MG INTRANASAL EPINEPHRINE TREATMENT IN CONGESTION SHOWS INCREASED BIOAVAILABILITY WITHOUT PHARMACOKINETIC AND PHARMACODYNAMIC CORRELATION
- Source :
- Annals of Allergy, Asthma & Immunology; November 2023, Vol. 131 Issue: 5, Number 5 Supplement 1 pS15-S15, 1p
- Publication Year :
- 2023
-
Abstract
- 13.2 mg intranasal (IN/NDS1C) epinephrine demonstrates rapid absorption and overall exposure that increases with allergen-induced nasal congestion. The relationship between pharmacokinetics (PK) and pharmacodynamics (PD) was explored.
Details
- Language :
- English
- ISSN :
- 10811206
- Volume :
- 131
- Issue :
- 5, Number 5 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Annals of Allergy, Asthma & Immunology
- Publication Type :
- Periodical
- Accession number :
- ejs64260533
- Full Text :
- https://doi.org/10.1016/j.anai.2023.08.055